A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy
Not yet recruitingOBSERVATIONAL
Enrollment
350
Participants
Timeline
Start Date
August 6, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
October 30, 2027
Conditions
Non-Small Cell Lung Cancer
All Listed Sponsors
collaborator
Beijing Municipal Health Commission
OTHER_GOV
lead
Peking University People's Hospital
OTHER
NCT07119190 - A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy | Biotech Hunter | Biotech Hunter